Hello and Welcome to Patientsville.com, Your Source for all DOCUSATE information. We are dedicated to provide You with DOCUSATE safety information. Learn about DOCUSATE serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
DOCUSATE Safety Reports
Total DOCUSATE reports: 7.DOCUSATE FDA safety alerts: 2001 .
Reported deaths: 1 Reported hospitalizations: 3.
Take DOCUSATE Side Effects Survey or Share Your DOCUSATE Story. Read More Here.
Health Professional from UNITED STATES reported DOCUSATE problem on May 23, 2007. Female patient, 63 years of age, weighting 187.0 lb, was diagnosed with constipation and was treated with DOCUSATE. After drug was administered, patient experienced the following problems/side effects: diarrhoea. DOCUSATE dosage: unknown. Patient recovered.
DOCUSATE problem was reported by a Pharmacist from UNITED STATES on Sept 28, 2006. Male patient, 86 years of age, was treated with DOCUSATE. After drug was administered, patient experienced the following problems/side effects: transient ischaemic attack. DOCUSATE dosage: 100 MG (50 MG, 2 IN 1 D); ORAL. Patient recovered.
Consumer or non-health professional from CANADA reported DOCUSATE problem on Sept 28, 2006. Male patient, 89 years of age, was diagnosed with constipation and was treated with DOCUSATE. After drug was administered, patient experienced the following problems/side effects: dysphagia, dysphonia, odynophagia, pneumonia aspiration, throat irritation. DOCUSATE dosage: 200 MG (100 MG, 2 IN 1 D), ORAL. Patient was hospitalized. Patient recovered.
DOCUSATE problem was reported by a Pharmacist from UNITED STATES on Oct 02, 2006. Male patient, 86 years of age, was diagnosed with laxative supportive care and was treated with DOCUSATE. After drug was administered, patient experienced the following problems/side effects: dysarthria, feeling drunk, transient ischaemic attack. DOCUSATE dosage: 200 MG (100 MG, 2 IN 1 D), ORAL. During the same period patient was treated with LABETALOL, CITALOPRAM HYDROBROMIDE, LATANOPROST, LEVETIRACETAM. Patient recovered.
Pharmacist from UNITED STATES reported DOCUSATE problem on Oct 02, 2006. Male patient, 86 years of age, was treated with DOCUSATE. After drug was administered, patient experienced the following problems/side effects: feeling drunk, transient ischaemic attack. DOCUSATE dosage: 200 MG (100 MG, 2 IN 1 D), ORAL. During the same period patient was treated with LABETALOL, CITALOPRAM HYDROBROMIDE, LATANOPROST, LEVETIRACETAM. Patient recovered.
DOCUSATE problem was reported by a Physician from UNITED STATES on May 31, 2006. Male patient, 69 years of age, weighting 154.3 lb, was diagnosed with cerebral haemorrhage and was treated with DOCUSATE. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, blood pressure increased, brain oedema, cerebral infarction. DOCUSATE dosage: 200 MG, QD. During the same period patient was treated with PEPCID, SIMVASTATIN, METOPROLOL TARTRATE, HYDROCHLOROTHIAZIDE, NOVOSEVEN. Patient was hospitalized and became disabled. Patient died on 06/03/2006.
Consumer or non-health professional from AUSTRALIA reported DOCUSATE problem on July 18, 2007. Female patient, 34 years of age, was treated with DOCUSATE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, abdominal tenderness, acidosis, acute hepatic failure, alanine aminotransferase increased, alopecia, aspartate aminotransferase increased, biliary sepsis, blood alkaline phosphatase increased. DOCUSATE dosage: unknown. During the same period patient was treated with COLCHICUM JTL LIQ, PARACETAMOL, TRAMADOL. Patient was hospitalized. Patient recovered.